{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-018849","form_type":"8-K","ticker":"ACH","cik":"0000075252","company_name":"ACCENDRA HEALTH INC/VA/","filed_at":"2025-02-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:06.273385+00:00","generated_at":"2026-05-27T04:21:56.608895+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Owens & Minor: preliminary Q4 net loss ~$300M, $310M goodwill impairment; launches financing for Rotech acquisition","bullets":["Q4 prelim rev $2.67-2.70B; net loss $(288-311)M; adj EBITDA $135-140M; adj EPS $0.52-0.55.","FY2024 prelim rev $10.67-10.70B; net loss $(355-378)M; adj EBITDA $520-525M; adj EPS $1.50-1.53.","Non-cash goodwill impairment ~$310M in Apria division from stock decline, rates, contract pricing.","Total debt reduced by over $240M in 2024; total debt ~$1.854-1.859B; net debt ~$1.805-1.810B.","Commenced financing for previously announced Rotech acquisition; expected close 1H 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-018849","json":"https://secwatch.observer/filing/0001193125-25-018849.json","markdown":"https://secwatch.observer/filing/0001193125-25-018849.md","text":"https://secwatch.observer/filing/0001193125-25-018849.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/75252/000119312525018849/0001193125-25-018849-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/75252/000119312525018849/d872714d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T04:21:56.608895+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}